Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Clinical Pharmacology

University Medical Centre Georg-August University Göttingen

Germany

Name/email consistency: high

Department of Clinical Pharmacology, University Medical Centre Georg-August University Göttingen, Germany. 2005
Institute of Clinical Pharmacology, Universitätsklinikum Charité, Humboldt Universität Berlin, D-10098, Germany. 2002 - 2004
Institute of Clinical Pharmacology and Department of Hematology and Oncology, University Medical Center Charité, Humboldt University of Berlin, Berlin, Germany. 2002

Antiemetic guidelines: are they being used?. Kaiser, R. Lancet Oncol. (2005) [Pubmed]
Investigation of the association between 5-HT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonists. Kaiser, R., Tremblay, P.B., Sezer, O., Possinger, K., Roots, I., Brockmöller, J. Pharmacogenetics (2004) [Pubmed]
L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. Kaiser, R., Hofer, A., Grapengiesser, A., Gasser, T., Kupsch, A., Roots, I., Brockmöller, J. Neurology (2003) [Pubmed]
Validity of PCR with emphasis on variable number of tandem repeat analysis. Kaiser, R., Tremblay, P.B., Roots, I., Brockmöller, J. Clin. Biochem. (2002) [Pubmed]
Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. Kaiser, R., Sezer, O., Papies, A., Bauer, S., Schelenz, C., Tremblay, P.B., Possinger, K., Roots, I., Brockmöller, J. J. Clin. Oncol. (2002) [Pubmed]